MET and hepatocellular carcinoma: A more recent study has shown, by in vitro and in vivo experiments, that HSC-secreted HGF might reduce HCC sensitization to chemotherapeutic agents by promoting epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC)-like properties through the HGF/c-Met pathway [142].